Correlation Between Enveric Biosciences and Effector Therapeutics
Can any of the company-specific risk be diversified away by investing in both Enveric Biosciences and Effector Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enveric Biosciences and Effector Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enveric Biosciences and Effector Therapeutics, you can compare the effects of market volatilities on Enveric Biosciences and Effector Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enveric Biosciences with a short position of Effector Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enveric Biosciences and Effector Therapeutics.
Diversification Opportunities for Enveric Biosciences and Effector Therapeutics
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Enveric and Effector is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Enveric Biosciences and Effector Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Effector Therapeutics and Enveric Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enveric Biosciences are associated (or correlated) with Effector Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Effector Therapeutics has no effect on the direction of Enveric Biosciences i.e., Enveric Biosciences and Effector Therapeutics go up and down completely randomly.
Pair Corralation between Enveric Biosciences and Effector Therapeutics
Given the investment horizon of 90 days Enveric Biosciences is expected to generate 1.0 times more return on investment than Effector Therapeutics. However, Enveric Biosciences is 1.0 times more volatile than Effector Therapeutics. It trades about -0.01 of its potential returns per unit of risk. Effector Therapeutics is currently generating about -0.05 per unit of risk. If you would invest 310.00 in Enveric Biosciences on August 23, 2024 and sell it today you would lose (276.00) from holding Enveric Biosciences or give up 89.03% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 80.24% |
| Values | Daily Returns |
Enveric Biosciences vs. Effector Therapeutics
Performance |
| Timeline |
| Enveric Biosciences |
| Effector Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Enveric Biosciences and Effector Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enveric Biosciences and Effector Therapeutics
The main advantage of trading using opposite Enveric Biosciences and Effector Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enveric Biosciences position performs unexpectedly, Effector Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Effector Therapeutics will offset losses from the drop in Effector Therapeutics' long position.| Enveric Biosciences vs. ZyVersa Therapeutics | Enveric Biosciences vs. Sonnet Biotherapeutics Holdings | Enveric Biosciences vs. Zura Bio Limited | Enveric Biosciences vs. Phio Pharmaceuticals Corp |
| Effector Therapeutics vs. Indaptus Therapeutics | Effector Therapeutics vs. Jasper Therapeutics | Effector Therapeutics vs. RenovoRx | Effector Therapeutics vs. Ensysce Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |